Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
immunotherapy
3
×
life sciences
national blog main
boston blog main
boston top stories
cancer
cancer immunotherapy
clinical trials
deals
medicare
national
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
abbvie
acute myeloid leukemia
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alx oncology
alzheimer's disease
american cancer society
amgen
antibiotics
autoimmune diseases
avelumab
axial spondyloarthritis
bausch health
berkeley lights
big pharma
biogen
biotech ipos
biovex
What
companies
3
×
bio
new
approval
approved
arrival
biogen’s
biopharmaceutical
biotech
cancer
combo
convo
dating
days
drug
earlier
failures
game
happening
hasn’t
immunotherapies
industry
ipo
ipos
kgaa
life
littered
market
medications
merck
momentum
nash
news
oncolytics
pfizer
pharmaceutical
price
raised
remains
research
Language
unset
Current search:
immunotherapy
×
companies
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
